TPS

Tectum Wins the Best Blockchain Innovation Award at the Leaders In Fintech Awards 2024

Retrieved on: 
Thursday, September 12, 2024
Bitcoin, Ethereum, TPS, Fintech, Ecosystem, Cryptocurrency

Victoria, Mahe, Seychelles, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Tectum, the fastest layer-1 blockchain, has received the Best Blockchain Innovation award at the Leaders in Fintech Awards 2024.

Key Points: 
  • Victoria, Mahe, Seychelles, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Tectum, the fastest layer-1 blockchain, has received the Best Blockchain Innovation award at the Leaders in Fintech Awards 2024.
  • This award recognizes Tectum as one of the most innovative blockchain services in the MENA region.
  • The Leaders in Fintech Awards 2024 comprises 38 different categories.
  • Tectum , the winner of the Best Blockchain Innovation Award at the Leaders In FinTech Awards 2024 is popular for having the fastest network with the highest number of transactions per second.

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

Retrieved on: 
Monday, September 9, 2024
Marie Cassidy, Roche, AI, Digital pathology, TPS, Therapy, Pathology, Research, Workflow, Biomarker, Health, PD-L1, PD, Algorithm, Medicine, Medical imaging

Roche's navify® Digital Pathology is an enterprise software application designed for the pathologist's workflow.

Key Points: 
  • Roche's navify® Digital Pathology is an enterprise software application designed for the pathologist's workflow.
  • The integrations aim to offer a comprehensive suite of digital pathology tools that enhance biomarker testing for cancer research and improve patient outcomes through precision medicine.
  • Lunit SCOPE PD-L1 22C3 TPS is an AI-powered tool that provides high-value insights and analysis of the PD-L1 tumor proportion score (TPS), a critical biomarker in cancer immunotherapy.
  • Lunit SCOPE PD-L1 TPS is for research use only, and is not for use in diagnostic procedures.

Omni Workspace welcomes Phillip Brown Jr. as General Manager of Turnkey Project Services, a commercial furniture and facility services company

Retrieved on: 
Thursday, September 5, 2024
Emerald, Philip, Acquisition, Architecture, Growth, TPS, Partnership, Philosophy, Overalls, Culture, Management

MINNEAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Omni Workspace is pleased to announce Phillip Brown Jr. as General Manager of their commercial furniture and facility services company, Turnkey Project Services (TPS), effective September 3, 2024.

Key Points: 
  • MINNEAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Omni Workspace is pleased to announce Phillip Brown Jr. as General Manager of their commercial furniture and facility services company, Turnkey Project Services (TPS), effective September 3, 2024.
  • Their purpose is to connect people through creative applications of architecture, furniture, and technology while delivering environments that are compelling, high-performing, and human-centric.
  • Phillip joins Turnkey Project Services with an extensive background in leading both operations and sales for key dealerships in the contract furniture industry.
  • Jesus Omana, President of Emerald Blue, who also oversees Omni Services, is thrilled to welcome Phillip to Turnkey's leadership team.

Coastal Windows & Conservatories (UK) Limited

Retrieved on: 
Wednesday, September 4, 2024
TPS, ICO

Coastal Windows & Conservatories Limited made over 18,000 unsolicited marketing calls between 1 January and 1 June 2023 to numbers registered with the TPS. The ICO and TPS received numerous complaints from people variously saying they had not consented to receiving such calls or received repeated calls despite requests to stop.

Key Points: 

Coastal Windows & Conservatories Limited made over 18,000 unsolicited marketing calls between 1 January and 1 June 2023 to numbers registered with the TPS. The ICO and TPS received numerous complaints from people variously saying they had not consented to receiving such calls or received repeated calls despite requests to stop.

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 59, Status: Authorised

Retrieved on: 
Wednesday, August 28, 2024
MSI-H, Pemetrexed, Fatigue, Ageing, ALK, Epithelium, Breast cancer, Rectum, Bile, Triple-negative breast cancer, Radiation, Neoplasm, Cancer, Doxorubicin, Medicine, Carboplatin, Docetaxel, ATC, Stomach, Oxaliplatin, Renal cell carcinoma, Skin cancer, Transitional cell carcinoma, Paclitaxel, Non-small-cell lung cancer, Tissue, CPS, BTC, CRC, RCC, Hodgkin lymphoma, Brentuximab vedotin, TPS, Transitional epithelium, Commission, Medical Subject Headings, PD, Cervical cancer, Cholangiocarcinoma, Bevacizumab, European Commission, Patient, Lung cancer, PD-L1, Endometrial cancer, MSI, Colorectal cancer, Kidney cancer, Capecitabine, Everolimus, European Medicines Agency, CHL, Neck, Cisplatin, Language, Recurrence, Immune system, TNBC, Human, Risk, Marketing, Liver, HER2, INN, IIA, Nausea, NSCLC, Probability, IIC, GEJ, Ipilimumab, Survival, Inflammation, ASCT, HNSCC, Select, International, PD-1, Trastuzumab, Large intestine, Diarrhea, Disease, Sunitinib, Platinum, Gallbladder, EGFR, System, Axitinib, Nephrectomy, CHMP, Anatomy, Cell, Esophageal cancer, Pharmaceutical industry

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 59, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 59, Status: Authorised

Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer

Retrieved on: 
Thursday, August 22, 2024
NCI, Cancer, Folate, Lung cancer, MD, Histology, TPS, Spacecraft, E pluribus unum, National Cancer Institute, Disease, Safety, Patient, Mortality, EGFR, Mutation, Survival rate, Diagnosis, STRO, NSCLC, SAN, Adenocarcinoma, Oncotarget, Pharmaceutical industry

“The initiation of REFRαME-L1 is an important milestone in our efforts to expand the application of luvelta to a broad range of patients with FRα expressing cancers.

Key Points: 
  • “The initiation of REFRαME-L1 is an important milestone in our efforts to expand the application of luvelta to a broad range of patients with FRα expressing cancers.
  • More than half of patients have metastatic disease at diagnosis, which has a 5-year survival rate as low as 8%2.
  • FRα has been found in multiple cancer types including NSCLC, but exhibits limited expression in normal tissue3,4,5.
  • REFRαME-L1 is a Phase 2 trial evaluating the safety and efficacy of luvelta in adult patients with previously treated advanced or metastatic NSCLC with FRα expression ≥25% Tumor Proportion Score (TPS).

Nokia and illwerke vkw AG announce state-of-the-art optical transport network in Austria

Retrieved on: 
Wednesday, August 21, 2024
PSS, Growth, MNO, Monolithic kernel, TPS, Fronthaul, DWDM, Senior, Telecommunications, Network equipment provider

Nokia optical network deployed to major sites across state of Vorarlberg, providing 10G, 25G and 100G mobile backhaul and fronthaul transport services.

Key Points: 
  • Nokia optical network deployed to major sites across state of Vorarlberg, providing 10G, 25G and 100G mobile backhaul and fronthaul transport services.
  • Vorarlberg, Austria – Nokia has been selected by illwerke vkw AG, a leading power utility and telecom service provider in Vorarlberg, Austria to deploy an optical transport solution to illwerke vkw’s business customers.
  • Christoph Märk, Head of IT at illwerke vkw AG, said: “We are excited to work with Nokia to evolve our existing network infrastructure.
  • Nokia will provide a resilient and superior optical transport network capable of supporting 400G wavelengths and beyond, which will serve the present and future requirements of illwerke vkw AG’s customers.”

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024

Retrieved on: 
Tuesday, August 20, 2024
Oncology, Therapy, GSK, TPS, Congress, ESMO, Abstract, NSCLC

WATERTOWN, Mass.

Key Points: 
  • WATERTOWN, Mass.
  • and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that interim data from GALAXIES Lung-201, the Phase 2 platform study sponsored by iTeos’ development partner GSK, assessing the belrestotug + dostarlimab doublet in previously untreated, unresectable, locally advanced or metastatic PD-L1 high non-small cell lung cancer, will be presented as a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress 2024, being held September 13-17, 2024 in Barcelona, Spain.
  • Title: Interim Analysis of GALAXIES Lung-201: Phase 2, Randomized, Open-label Platform Study of Belrestotug Plus Dostarlimab in Patients (pts) With Previously Untreated Locally Advanced/Metastatic (LA/M) PD-L1 High (TPS >/=50%) Non-Small Cell Lung Cancer (NSCLC)
    The ESMO website indicates that all late-breaking abstracts will be published on the ESMO website on the day of the presentation at 00:05 am CEST.

Fibonacci (FIBO) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Monday, August 12, 2024
FIBO, COSMOS, Web3, Ecosystem, Beauty, TPS, Cryptocurrency

Fibonacci (FIBO) is the native cryptocurrency of the Fibonacci blockchain, designed to facilitate high-performance, low-cost transactions and support the development of a social and creator economic ecosystem.

Key Points: 
  • Fibonacci (FIBO) is the native cryptocurrency of the Fibonacci blockchain, designed to facilitate high-performance, low-cost transactions and support the development of a social and creator economic ecosystem.
  • LBank Exchange is thrilled to announce the listing of Fibonacci (FIBO), a groundbreaking commercial public blockchain that targets the social domain, aiming to create a vibrant ecosystem for social interactions and creator economics.
  • Named after the famous mathematician and his eponymous sequence, Fibonacci symbolizes simplicity, natural order, and beauty.
  • FlySwap offers a decentralized trading protocol for transparent and secure cryptocurrency transactions, while FigBox provides a multi-chain encrypted wallet supporting various cryptocurrencies.

AGCO suspends the liquor sales licence of Scarborough karaoke bar WAVE KTV following police investigation of alleged confinement, assault and kidnapping of patron

Retrieved on: 
Friday, August 9, 2024
WAVE, Toronto Police Service, Registrar, AGCO, Alcohol, Safety, TPS, Police

As of this date, this establishment is not legally allowed to sell or serve alcohol.

Key Points: 
  • As of this date, this establishment is not legally allowed to sell or serve alcohol.
  • The AGCO received information from the Toronto Police Service (TPS) that a serious incident allegedly occurred at WAVE KTV on July 19, 2024.
  • Based on an ongoing Toronto Police Service criminal investigation, the Registrar has considered it necessary in the public interest to immediately suspend the liquor licence of this establishment.
  • "The licence to sell or serve liquor is a public trust that comes with clear responsibilities of legal, responsible conduct and behaviour.